Most of the company’s new additions, if not already online, will be scheduled for commissioning, validation, or qualification before the fourth quarter of 2025.
The global contract packaging organization
In a press release on June 5, 2025, Tjoapack detailed the changes planned for the facilities in Clinton, Tenn., in the US, and at Etten-Leur in The Netherlands.
At the Clinton site, Tjoapack is completing installation of two advanced packaging lines that will support high-throughput, sterile packaging operations (1). A line expected to be completed in the second quarter of 2025 is high-speed and fully automated for vial packaging, with an annual processing capability of 20 million vials—including integrated labeling, cartooning, and serialization. In the third quarter, a semi-automated auto-injector line that offers end-to-end traceability and labeling will be scheduled for qualification. Cold storage capacity at this site has been expanded and validated, providing a total of 160 good manufacturing practice-compliant pallet spaces in controlled 2–8°C conditions.
The Etten-Leur facility has also seen its cold chain capacity increase, bringing on 84 additional pallet spaces to push its total to 120, under the same temperature guidelines. This site, according to Tjoapack, additionally has completed its first commercial project for prefilled syringe (PFS) packaging (1). The fully automated PFS line offers syringe assembly with or without safety devices, automated plunger rod insertion, and insertion of ancillary components like needles, among other features.
“These upgrades directly address the accelerating needs of our clients in the biologics and sterile injectable space,” said
In
“The development of PFS and auto-injectors has simplified the injection process, making it easier for patients to self-administer biologics at home,” Compton said (2). “Auto-injectors are designed for intuitive use, often requiring a single step to deliver the medication. This eliminates the complexity of traditional injections, which involve multiple steps like preparing the syringe, measuring the dose, and administering the injections. Auto-injectors feature ergonomic designs and clear instructions, making them easy to handle and operate, even for patients with limited dexterity or those unfamiliar with injections.”
At the Drug, Chemical & Associated Technologies Association
“We've been investing heavily in expanding our cold chain capabilities, in expanding our capability and capacity to package unique configuration for injectable products, whether that is a product that comes to us in a syringe format, a vial format, or an auto injector format,” Belden said (3). “[We have] the ability to either automate or semi-automate, label, and then finish [to] pack those products while maintaining tight control of time [and] temperature to allow for packaging, and then getting those materials and finished goods back into cold storage.”
The full interview with Belden can be seen
1. Tjoapack. Tjoapack Continues to Expand Its Global Infrastructure with Strategic Investments in Injectable Packaging and Cold Chain Capabilities. Press Release. June 5, 2025.
2. Compton, J.
3. Haigney, S.
